Colorectal Cancer Screening (Blood) Test
Colorectal Cancer (CRC), which includes both Rectal and Colon Cancer, is currently recognized as the third most common cancer diagnosis in the US, with rates of diagnosis increasing in younger populations (younger than 50 years of age) ever since the mid-1990s. The risk for getting this, or any, type of cancer can vary due to many different factors like age, race, gender, family history, personal history, etc.; however, the early identification of that risk is essential to ensuring an early diagnosis, and thus earlier and usually easier treatments when necessary.
Screening for CRC has previously only been performed through invasive procedures like a colonoscopy, which can be a complicated and expensive procedure for some. Other studies have been developed to look for suspicious markers, or things to make your provider suspect the possibility of CRC; but these too have relied on stool (fecal) samples for testing. Any Lab Test Now is able to offer a cutting-edge screening test for screening for the risk of CRC in any patient 45 years of age and older. Three specific protein markers in the blood have been highly associated with the presence of CRC. By looking for these markers, a simple blood test can now tell you of the possible presence or not for colorectal cancer.
While this test should not replace regular check-ups with your healthcare provider, and a colonoscopy might still be recommended or needed; this test can provide an additional step for early detection, without much more complicated or difficult testing.
All results should be provided to your physician for additional interpretation and follow-up.
This test is indicated for people 45-80 years of age, at average risk for colorectal cancer, and who are unable or unwilling to participate in other recommended colorectal cancer screening tests. This test is not intended for people with family or personal history of colorectal cancer or colorectal polyps. This test is also not intended for people who have an inflammatory disease, people who are pregnant or nursing, people who are receiving chemotherapy or radiation, and people who are less than 60 days post-surgical procedure.